Tura S - Search Results

1

Results in hairy-cell leukemia patients treated with alpha-interferon: predictive prognostic factors.

Zinzani PL, Lauria F, Raspadori D, Rondelli D, Benfenati D, Pileri S, Sabattini E, Tura S. Zinzani PL, et al. Among authors: tura s. Eur J Haematol. 1992 Sep;49(3):133-7. doi: 10.1111/j.1600-0609.1992.tb00917.x. Eur J Haematol. 1992. PMID: 1446727

2

Serum soluble interleukin-2 receptor levels in hairy cell leukemia: correlation with clinical and hematological parameters and with alpha-interferon treatment.

Lauria F, Rondelli D, Raspadori D, Zinzani PL, Benfenati D, Pileri S, Sabattini E, Tura S. Lauria F, et al. Among authors: tura s. Leuk Lymphoma. 1992 May;7(1-2):103-7. doi: 10.3109/10428199209053608. Leuk Lymphoma. 1992. PMID: 1472920

3

Reduced hematologic response to alpha-interferon therapy in patients with hairy cell leukemia showing a peculiar immunologic phenotype.

Lauria F, Raspadori D, Foa R, Zinzani PL, Buzzi M, Gugliotta L, Macchi S, Tura S. Lauria F, et al. Among authors: tura s. Cancer. 1990 May 15;65(10):2233-6. doi: 10.1002/1097-0142(19900515)65:10<2233::aid-cncr2820651012>3.0.co;2-k. Cancer. 1990. PMID: 1693308

4

Is interferon alpha in cutaneous T-cell lymphoma a treatment of choice?

Papa G, Tura S, Mandelli F, Vegna ML, Defazio D, Mazza P, Zinzani PL, Simoni R, DePita O, Ferranti G, et al. Papa G, et al. Among authors: tura s. Br J Haematol. 1991 Oct;79 Suppl 1:48-51. doi: 10.1111/j.1365-2141.1991.tb08119.x. Br J Haematol. 1991. PMID: 1931709

5

Comparison of low-dose versus standard-dose alpha-interferon regimen in the hairy cell leukemia treatment.

Zinzani PL, Lauria F, Raspadori D, Buzzi M, Benfenati D, Bocchia M, Rondelli D, Tura S. Zinzani PL, et al. Among authors: tura s. Acta Haematol. 1991;85(1):16-9. doi: 10.1159/000204845. Acta Haematol. 1991. PMID: 2011924 Clinical Trial.

6

Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: therapeutic perspective.

Mazza P, Tura S, Bocchia M, Zinzani PL, Gherlinzoni F, Mandelli F, Anselmo MP, Papa G, Antimi M, Gobbi PG, et al. Mazza P, et al. Among authors: tura s. Eur J Haematol Suppl. 1990;52:22-4. doi: 10.1111/j.1600-0609.1990.tb00900.x. Eur J Haematol Suppl. 1990. PMID: 2279540 Clinical Trial.

7

Relationship between immunological phenotype and hematological response to alpha-IFN treatment in 35 patients with hairy cell leukemia.

Lauria F, Zinzani PL, Raspadori D, Foà R, Buzzi M, Gugliotta L, Bocchia M, Benfenati D, Tura S. Lauria F, et al. Among authors: tura s. Eur J Haematol Suppl. 1990;52:3-6. doi: 10.1111/j.1600-0609.1990.tb00895.x. Eur J Haematol Suppl. 1990. PMID: 2279543

8

Hairy cell leukemia variant: a morphologic, immunologic and clinical study of 7 cases.

Zinzani PL, Lauria F, Buzzi M, Raspadori D, Gugliotta L, Bocchia M, Macchi S, Algeri R, Tura S. Zinzani PL, et al. Among authors: tura s. Haematologica. 1990 Jan-Feb;75(1):54-7. Haematologica. 1990. PMID: 2338288

9

Evaluation of complete remission in hairy cell leukemia patients treated with alpha-IFN.

Lauria F, Foà R, Raspadori D, Pileri S, Tassinari A, Buzzi M, Zaccaria A, Zinzani PL, Tura S. Lauria F, et al. Among authors: tura s. Bone Marrow Transplant. 1989 Jan;4 Suppl 1:176-8. Bone Marrow Transplant. 1989. PMID: 2785426

10

FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low-grade non-Hodgkin's lymphoma.

Zinzani PL, Bendandi M, Tura S. Zinzani PL, et al. Among authors: tura s. Eur J Haematol. 1995 Oct;55(4):262-6. doi: 10.1111/j.1600-0609.1995.tb00269.x. Eur J Haematol. 1995. PMID: 7589345 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

718 results

Search Page

Filters